NRG-BN009 is a clinical study for people with cancer that has spread to the brain and come back in other areas of the brain after earlier stereotactic radiosurgery (SRS). Brain Metastasis Velocity (BMV) is a measure of how fast the cancer is spreading in your brain. If you have a BMV of four or higher, more treatment is needed to control the spread of cancer in your brain.
The usual treatment for your brain cancer is SRS that delivers a high dose of radiation only to the small areas of cancer in the brain but does not treat even smaller areas of cancer that cannot be seen in the brain.
Researchers are doing this study to find out if they can extend your life by using a type of radiation therapy called whole-brain radiation therapy that preserves memory by avoiding the hippocampus and using the medication memantine. Researchers will be comparing whole-brain radiation therapy using memory-preserving approaches to the usual treatment of SRS.
More information about this particular study is located on ClinicalTrials.gov
Are you interested in joining the study? Find a participating location
Below, you can find FAQs about clinical research and this particular clinical trial.
Talk to your insurance provider and make sure that you understand what your insurance pays for and what it does not pay for if you take part in this clinical trial. Also, find out if you need approval from your plan before you can take part in the study.
You will not be paid for taking part in this study.
Doctors and researchers conduct a clinical study, also called a “clinical trial,” to find better ways to prevent, diagnose, or treat an illness. NRG Oncology is supported by the National Cancer Institute (NCI) and runs clinical studies specifically for patients with cancer or to prevent cancer. Most clinical studies test something we know against something we don’t know. In all situations, these studies are strictly evaluated before they are allowed to be offered to any patient. The study is designed to answer the question that we do not know the answer to, so that current and future patients may have better treatments or information than what we currently have. There are different types of clinical studies that might be available for patients. For more information see “Types of Clinical Trials” and “Phases of Clinical Trials”.
Patients who volunteer to take part in a clinical study are followed closely by their health care professionals and members of the research team. For more information see “Research Team Members”.
At NRG Oncology, we focus on conducting clinical studies aimed to improve current cancer care practices and the lives of cancer patients. NRG Oncology partners with more than 1,300 member sites world-wide to research ways to improve treatment standards in the cancer community. Our organization is supported primarily through grants from the National Cancer Institute (NCI) and is one of five research groups in the NCI's National Clinical Trial's Network.